David J Breen, Southampton, UK, gave delegates at ECIO 2012 (Florence, Italy, 25–28 April) 10 top tips for optimising outcomes in microwave ablation of the liver. [read more]
Randomised evidence on the use of drug-eluting microspheres in colorectal cancer, long-term outcomes of thermal ablation for metastatic tumours in the lung and improvements in long-term survival of hepatocellular carcinoma will be some of the highlights scheduled at the World Conference on Interventional Oncology (Chicago, USA, 14–17 June 2012). [read more]
The European Conference on Interventional Oncology (ECIO) held its third congress from 25–28 April in Florence. Interventional management of hepatocellular carcinoma and training in interventional oncology were the key themes at this year’s conference. [read more]
CT-Guide navigation allows physicians to determine the location of the navigated instrument in relation to the 3D space of the CT images and the desired target, continuously displaying the location of the instrument and its planned path on the CT image of the patient’s anatomy. [read more]
Trovagene announced that it has successfully completed the analytical development of digital PCR assays for the detection of the most prevalent K-RAS mutations, which are, according to recent estimates, observed in more than 90% of pancreatic cancers and in 23% of all solid tumours. [read more]
The collaboration covers the mutual marketing and representation of products for imaging and treatment in the global radiation oncology business. [read more]
The study will evaluate and compare the safety and efficacy of TheraSphere vs. sorafenib in hepatocellular carcinoma patients with portal vein thrombosis [read more]
Microsulis Medical has announced that it will host a satellite symposium titled “2.45GHz microwave ablation: top tips to improve outcomes in the liver and lung” at the European Conference on Interventional Oncology (ECIO) this week. [read more]
